Abbott Laboratories Revenue 2006-2019 | ABT

Abbott Laboratories annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Abbott Laboratories revenue for the quarter ending September 30, 2019 was $8.076B, a 5.49% increase year-over-year.
  • Abbott Laboratories revenue for the twelve months ending September 30, 2019 was $31.355B, a 3.13% increase year-over-year.
  • Abbott Laboratories annual revenue for 2018 was $30.578B, a 11.64% increase from 2017.
  • Abbott Laboratories annual revenue for 2017 was $27.39B, a 31.35% increase from 2016.
  • Abbott Laboratories annual revenue for 2016 was $20.853B, a 2.2% increase from 2015.
Abbott Laboratories Annual Revenue
(Millions of US $)
2018 $30,578
2017 $27,390
2016 $20,853
2015 $20,405
2014 $20,247
2013 $19,657
2012 $19,050
2011 $21,407
2010 $35,167
2009 $30,765
2008 $29,528
2007 $25,914
2006 $22,476
2005 $22,338
Abbott Laboratories Quarterly Revenue
(Millions of US $)
Q3 2019 $8,076
Q2 2019 $7,979
Q1 2019 $7,535
Q4 2018 $7,765
Q3 2018 $7,656
Q2 2018 $7,767
Q1 2018 $7,390
Q4 2017 $7,589
Q3 2017 $6,829
Q2 2017 $6,637
Q1 2017 $6,335
Q4 2016 $5,333
Q3 2016 $5,302
Q2 2016 $5,333
Q1 2016 $4,885
Q4 2015 $5,188
Q3 2015 $5,150
Q2 2015 $5,170
Q1 2015 $4,897
Q4 2014 $5,356
Q3 2014 $5,079
Q2 2014 $5,057
Q1 2014 $4,755
Q4 2013 $4,008
Q3 2013 $4,825
Q2 2013 $5,446
Q1 2013 $5,378
Q4 2012 $3,188
Q3 2012 $5,265
Q2 2012 $5,313
Q1 2012 $5,284
Q4 2011 $10,377
Q3 2011 $9,817
Q2 2011 $9,616
Q1 2011 $9,041
Q4 2010 $9,968
Q3 2010 $8,675
Q2 2010 $8,826
Q1 2010 $7,698
Q4 2009 $8,790
Q3 2009 $7,761
Q2 2009 $7,495
Q1 2009 $6,718
Q4 2008 $7,950
Q3 2008 $7,498
Q2 2008 $7,314
Q1 2008 $6,766
Q4 2007 $7,221
Q3 2007 $6,377
Q2 2007 $6,371
Q1 2007 $5,946
Q4 2006 $6,821
Q3 2006 $5,574
Q2 2006 $5,501
Q1 2006 $4,580
Q4 2005 $6,047
Q3 2005 $5,384
Q2 2005 $5,524
Q1 2005 $5,383
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $150.637B $30.578B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $150.042B 20.73
Stryker (SYK) United States $76.456B 25.71
Boston Scientific (BSX) United States $59.948B 28.30
Baxter (BAX) United States $42.085B 25.52
Essilor Luxottica (ESLOY) France $33.039B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.517B 19.15
Terumo (TRUMY) Japan $27.707B 34.58
Coloplast (CLPBY) Denmark $25.466B 39.30
Lonza Group Ag (LZAGY) Switzerland $25.140B 0.00
ResMed (RMD) United States $21.589B 39.83
Smith & Nephew SNATS (SNN) United Kingdom $19.156B 0.00
Sunny Optical Technology (SNPTF) China $17.572B 0.00
Insulet (PODD) United States $11.307B 537.91
Bio-Rad Laboratories (BIO) United States $11.116B 53.36
DiaSorin S.p.A (DSRLF) Italy $7.580B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Hill-Rom Holdings (HRC) United States $7.111B 20.97
Perrigo (PRGO) Ireland $6.899B 12.86
Canopy Growth (CGC) Canada $6.407B 0.00
Haemonetics (HAE) United States $6.041B 40.82
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.822B 30.09
ICU Medical (ICUI) United States $3.799B 24.77
Neogen (NEOG) United States $3.543B 59.28
GW Pharmaceuticals (GWPH) United Kingdom $3.272B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.243B 0.00
Quidel (QDEL) United States $2.849B 27.04
Aurora Cannabis (ACB) Canada $2.702B 0.00
Agios Pharmaceuticals (AGIO) United States $2.371B 0.00
National Vision Holdings (EYE) United States $2.367B 53.43
Cardiovascular Systems (CSII) United States $1.555B 0.00
InMode (INMD) Israel $1.371B 0.00
Aphria (APHA) $1.175B 0.00
AtriCure (ATRC) United States $1.173B 0.00
VAREX IMAGING (VREX) United States $1.161B 23.26
Phibro Animal Health (PAHC) United States $0.983B 18.41
NanoString Technologies (NSTG) United States $0.953B 0.00
TG Therapeutics (TGTX) United States $0.816B 0.00
Lantheus Holdings (LNTH) United States $0.793B 19.80
Eagle Pharmaceuticals (EGRX) United States $0.762B 29.17
Omeros (OMER) United States $0.758B 0.00
LeMaitre Vascular (LMAT) United States $0.719B 40.44
Quanterix (QTRX) United States $0.689B 0.00
PetIQ (PETQ) United States $0.644B 15.72
Cerus (CERS) United States $0.587B 0.00
Surmodics (SRDX) United States $0.553B 57.44
HEXO (HEXO) $0.548B 0.00
OraSure Technologies (OSUR) United States $0.476B 28.56
MacroGenics (MGNX) United States $0.473B 0.00
Owens & Minor (OMI) United States $0.439B 16.23
Organigram Holdings (OGI) Canada $0.401B 0.00
Utah Medical Products (UTMD) United States $0.395B 28.61
Meridian Bioscience (VIVO) United States $0.389B 13.37
Zynex (ZYXI) United States $0.341B 38.52
BioLife Solutions (BLFS) United States $0.332B 135.17
Bovie Medical (APYX) United States $0.271B 0.00
United Health Products (UEEC) United States $0.263B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.256B 0.00
Viemed Healthcare (VMD) United States $0.230B 24.28
Vapotherm (VAPO) United States $0.223B 0.00
Liberty Health Sciences (LHSIF) Canada $0.187B 0.00
Repro-Med Systems (KRMD) United States $0.187B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.178B 0.00
InfuSystems Holdings (INFU) United States $0.158B 796.00
Chimerix (CMRX) United States $0.155B 0.00
Female Health (VERU) United States $0.142B 0.00
Rockwell Medical (RMTI) United States $0.134B 0.00
MTech Acquisition (KERN) United States $0.128B 0.00
Fonar (FONR) United States $0.127B 8.92
Cytosorbents (CTSO) United States $0.122B 0.00
United-Guardian (UG) United States $0.092B 23.27
Oramed Pharmaceuticals (ORMP) United States $0.081B 0.00
Chembio Diagnostics (CEMI) United States $0.071B 0.00
Nephros (NEPH) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.058B 0.00
Surface Oncology (SURF) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.025B 0.00
Senestech (SNES) United States $0.016B 0.00
GUARDION HEALTH (GHSI) United States $0.016B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.003B 0.00